Holen Sie sich die Stockscreener-App
39.11
1.04%
-0.41
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
RSI Suggests Rebound May Be Near in Collegium Pharmaceutical Inc.July 2025 Big Picture & Growth Oriented Trade Recommendations - beatles.ru
Developing predictive dashboards with Collegium Pharmaceutical Inc. dataMarket Trend Review & Free Technical Confirmation Trade Alerts - Newser
What indicators show strength in Collegium Pharmaceutical Inc.July 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser
Will Collegium Pharmaceutical Inc. stock go up soon2025 Trading Recap & Low Risk High Reward Ideas - Newser
Collegium Pharmaceutical Inc. stock chart pattern explainedMarket Growth Summary & AI Forecast for Swing Trade Picks - Newser
Full technical analysis of Collegium Pharmaceutical Inc. stock2025 Investor Takeaways & Weekly Momentum Picks - Newser
What MACD signals say about Collegium Pharmaceutical Inc.Trade Risk Report & Free Long-Term Investment Growth Plans - Newser
Trend analysis for Collegium Pharmaceutical Inc. this week2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Is Collegium Pharmaceutical Inc. stock poised for growthPortfolio Value Summary & High Conviction Investment Ideas - Newser
Collegium Pharmaceutical Inc. stock prediction for this weekPortfolio Risk Summary & Technical Entry and Exit Alerts - Newser
Is Collegium Pharmaceutical Inc. still worth holding after the dipEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Risk adjusted return profile for Collegium Pharmaceutical Inc. analyzedMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Technical analysis overview for Collegium Pharmaceutical Inc. stockCPI Data & Free Community Supported Trade Ideas - Newser
Is this a good reentry point in Collegium Pharmaceutical Inc.Rate Hike & Weekly Setup with ROI Potential - Newser
Backtesting results for Collegium Pharmaceutical Inc. trading strategiesInsider Buying & Free Technical Pattern Based Buy Signals - Newser
Maryland State Retirement & Pension System Reduces Position in Collegium Pharmaceutical, Inc. $COLL - Defense World
Sector ETF performance correlation with Collegium Pharmaceutical Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
How to build a dashboard for Collegium Pharmaceutical Inc. stockWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Rubric Capital Management Sells 25,000 Collegium Pharmaceutical Shares for $946,250 - AInvest
How to use a screener to detect Collegium Pharmaceutical Inc. breakoutsJuly 2025 Fed Impact & Free Long-Term Investment Growth Plans - Newser
Multi asset correlation models including Collegium Pharmaceutical Inc.Earnings Risk Report & Real-Time Volume Spike Alerts - Newser
What data driven models say about Collegium Pharmaceutical Inc.’s future2025 Key Highlights & Risk Controlled Stock Alerts - Newser
Can momentum traders help lift Collegium Pharmaceutical Inc.July 2025 Technicals & Verified Momentum Stock Alerts - Newser
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by HC Wainwright to "Strong-Buy" Rating - MarketBeat
Is Collegium Pharmaceutical's (COLL) Revenue Guidance and Buyback Balancing Short-Term Results With Long-Term Value? - simplywall.st
Major Shareholder Offloads Thousands of Collegium Pharmaceutical Shares! - TipRanks
Collegium pharma EVP Dreyer sells $184,880 in stock - Investing.com
Collegium pharma EVP Dreyer sells $184,880 in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical EVP Scott Dreyer Sells 4,861 Shares, Buys 4,861 at $38.03/Share. - AInvest
Have Collegium Pharmaceutical Insiders Been Selling Stock? - 富途牛牛
Published on: 2025-08-16 02:26:13 - thegnnews.com
We Think You Can Look Beyond Collegium Pharmaceutical's (NASDAQ:COLL) Lackluster Earnings - Yahoo Finance
How Collegium Pharmaceutical Inc. stock performs during market volatility2025 Trading Recap & Safe Capital Growth Plans - beatles.ru
Collegium Pharmaceutical Inc. Nearing Breakout Level After BounceJuly 2025 Gainers & Safe Entry Trade Reports - beatles.ru
The 5 Most Interesting Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to “Strong-Buy” at HC Wainwright - Defense World
Can Collegium Pharmaceutical Inc. recover in the next quarterJuly 2025 Reactions & Safe Capital Growth Plans - Newser
Quant Tools Rank Collegium Pharmaceutical Inc. as High Risk High RewardEarnings Beat & Short-Term Trading Opportunity Alerts - newsyoung.net
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics - msn.com
Collegium Pharmaceutical Inc. Bounces Off Moving Average SupportQuarterly Trade Summary & Long Hold Capital Preservation Tips - sundaytimes.kr
Published on: 2025-08-13 16:47:11 - beatles.ru
IBD Rating Upgrades: Collegium Pharmaceutical Flashes Improved Relative Price Strength - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by Wall Street Zen to "Strong-Buy" Rating - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by HC Wainwright to Strong-Buy Rating - Defense World
3 Profitable Stocks We Think Twice About - Yahoo Finance
Collegium Pharmaceutical Q2 Earnings: Revenue Beats Estimates, Margin Pressure from Investments - AInvest
COLL Q2 Deep Dive: Jornay Expansion Drives Revenue Guidance Increase, Margins Face Investment Pressure - Yahoo Finance
Collegium Pharmaceutical Shows Market Leadership With Jump To 81 RS Rating - Investor's Business Daily
Collegium Pharmaceutical Earns Membership In 95-Plus Composite Rating Club - MSN
H.C. Wainwright assumes coverage on Collegium Pharmaceutical stock with Buy rating - Investing.com Canada
Collegium Pharmaceutical (COLL) Is Up 16.2% After Raising 2025 Revenue Guidance on Strong Q2 Results - simplywall.st
Collegium Pharmaceutical's Q2 2025: Key Contradictions on Jornay PM Sales Estimates and Pain Portfolio Competition - AInvest
2.37%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):